Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07848737) titled 'A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis' on Sept. 24.
Study Type: Observational
Primary Sponsor: Janssen-Cilag, S.A.
Condition:
Colitis, Ulcerative
Crohn Disease
Recruitment Status: Not recruiting
Date of First Enrollment: October 30, 2026
Target Sample Size: 200
To know more, visit https://clinicaltrials.gov/study/NCT07848737
Published by HT Digital Content Services with permission from Health Daily Digest....